The JCA is the scientific compilation and the description of a comparative analysis of the available clinical evidence on a health technology in comparison with one or more other health technologies or existing procedures – the full definition is provided under Chapter I Article 2 (6)  in the HTAR 2021/2282. Available at:  Publications Office (europa.eu)

Joint Clinical Assessments (Art. 7–15): A Joint Clinical Assessment (JCA) of a health technology involves a comparative analysis of available clinical evidence on the health technology in comparison with other health technologies or existing procedures. (Art. 7–15) Available at: Regulation - 2021/2282 - EN - EUR-Lex (europa.eu)

Joint Scientific Consultations (Art. 16–21): A Joint Scientific Consultation (JSC) aims to advice the Health Technology Developer on evidence likely to be required in a subsequent Joint Clinical Assessment of a health technology.

Health technologies eligible for joint scientific consultations are those for which a joint clinical assessment hasn't been planned but are likely candidates. These consultations occur at the request of the developer.